Nakazawa S, Pecci F, Ricciuti B, Gottlieb FH, et al. Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC. J Thorac Oncol 2025;20:1035-1049.
PMID: 40185329